7,7,12,16-Tetramethyl-15-(4,5,6-trihydroxy-6-methylheptan-2-yl)pentacyclo[9.7.0.01,3.03,8.012,16]octadecane-6,9,14-triol
| Internal ID | 45df6ce6-e91b-4b3d-a601-b82892d65541 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Cycloartanols and derivatives |
| IUPAC Name | 7,7,12,16-tetramethyl-15-(4,5,6-trihydroxy-6-methylheptan-2-yl)pentacyclo[9.7.0.01,3.03,8.012,16]octadecane-6,9,14-triol |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C30H52O6/c1-16(12-18(32)24(35)26(4,5)36)22-19(33)14-28(7)20-13-17(31)23-25(2,3)21(34)8-9-30(23)15-29(20,30)11-10-27(22,28)6/h16-24,31-36H,8-15H2,1-7H3 |
| InChI Key | TXTHDULUXAJMIG-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C30H52O6 |
| Molecular Weight | 508.70 g/mol |
| Exact Mass | 508.37638937 g/mol |
| Topological Polar Surface Area (TPSA) | 121.00 Ų |
| XlogP | 3.60 |
| Atomic LogP (AlogP) | 3.25 |
| H-Bond Acceptor | 6 |
| H-Bond Donor | 6 |
| Rotatable Bonds | 5 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9525 | 95.25% |
| Caco-2 | - | 0.7439 | 74.39% |
| Blood Brain Barrier | + | 0.6000 | 60.00% |
| Human oral bioavailability | - | 0.6000 | 60.00% |
| Subcellular localzation | Mitochondria | 0.4971 | 49.71% |
| OATP2B1 inhibitior | - | 0.5766 | 57.66% |
| OATP1B1 inhibitior | + | 0.8455 | 84.55% |
| OATP1B3 inhibitior | + | 0.9487 | 94.87% |
| MATE1 inhibitior | - | 1.0000 | 100.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | - | 0.8108 | 81.08% |
| P-glycoprotein inhibitior | - | 0.5991 | 59.91% |
| P-glycoprotein substrate | - | 0.5262 | 52.62% |
| CYP3A4 substrate | + | 0.6623 | 66.23% |
| CYP2C9 substrate | + | 0.5963 | 59.63% |
| CYP2D6 substrate | - | 0.7274 | 72.74% |
| CYP3A4 inhibition | - | 0.8392 | 83.92% |
| CYP2C9 inhibition | - | 0.7173 | 71.73% |
| CYP2C19 inhibition | - | 0.7116 | 71.16% |
| CYP2D6 inhibition | - | 0.9541 | 95.41% |
| CYP1A2 inhibition | - | 0.7475 | 74.75% |
| CYP2C8 inhibition | - | 0.6558 | 65.58% |
| CYP inhibitory promiscuity | - | 0.9317 | 93.17% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.7150 | 71.50% |
| Eye corrosion | - | 0.9898 | 98.98% |
| Eye irritation | - | 0.9260 | 92.60% |
| Skin irritation | + | 0.4913 | 49.13% |
| Skin corrosion | - | 0.9186 | 91.86% |
| Ames mutagenesis | - | 0.6700 | 67.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3627 | 36.27% |
| Micronuclear | - | 0.8700 | 87.00% |
| Hepatotoxicity | - | 0.6572 | 65.72% |
| skin sensitisation | - | 0.7663 | 76.63% |
| Respiratory toxicity | + | 0.6333 | 63.33% |
| Reproductive toxicity | + | 0.9444 | 94.44% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | - | 0.8518 | 85.18% |
| Acute Oral Toxicity (c) | III | 0.4070 | 40.70% |
| Estrogen receptor binding | + | 0.6783 | 67.83% |
| Androgen receptor binding | + | 0.7596 | 75.96% |
| Thyroid receptor binding | + | 0.6005 | 60.05% |
| Glucocorticoid receptor binding | + | 0.6790 | 67.90% |
| Aromatase binding | + | 0.6791 | 67.91% |
| PPAR gamma | + | 0.5588 | 55.88% |
| Honey bee toxicity | - | 0.7180 | 71.80% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.5200 | 52.00% |
| Fish aquatic toxicity | + | 0.9611 | 96.11% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.63% | 97.25% |
| CHEMBL3837 | P07711 | Cathepsin L | 97.84% | 96.61% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 96.82% | 95.58% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 96.75% | 95.69% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.09% | 97.09% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 94.85% | 96.09% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.39% | 91.11% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 94.25% | 95.93% |
| CHEMBL2581 | P07339 | Cathepsin D | 92.39% | 98.95% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 91.75% | 97.79% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 91.72% | 97.64% |
| CHEMBL204 | P00734 | Thrombin | 91.29% | 96.01% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 90.09% | 90.17% |
| CHEMBL238 | Q01959 | Dopamine transporter | 89.62% | 95.88% |
| CHEMBL268 | P43235 | Cathepsin K | 89.46% | 96.85% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 88.31% | 85.14% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 88.18% | 90.24% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 88.15% | 85.31% |
| CHEMBL240 | Q12809 | HERG | 87.76% | 89.76% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 87.44% | 92.86% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 87.43% | 95.27% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 86.81% | 91.03% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 86.70% | 82.69% |
| CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 86.66% | 100.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 86.46% | 98.05% |
| CHEMBL1741186 | P51449 | Nuclear receptor ROR-gamma | 86.33% | 99.17% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.70% | 100.00% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 84.67% | 89.34% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 84.57% | 100.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.62% | 95.89% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.39% | 100.00% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 83.37% | 98.10% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 83.16% | 90.93% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 82.90% | 98.75% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 82.34% | 95.00% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 82.25% | 99.17% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 82.22% | 92.50% |
| CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 | 82.18% | 95.42% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 82.13% | 94.45% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 81.71% | 96.95% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 81.29% | 93.85% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 80.82% | 97.14% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 80.45% | 92.88% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 80.37% | 99.18% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 80.26% | 89.62% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 80.21% | 89.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Astragalus orbiculatus |
| PubChem | 163048895 |
| LOTUS | LTS0104940 |
| wikiData | Q105266991 |